Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence SpGSpGPDGKTGPp
Primary information
sequence IDSeq_7460
Peptide sequenceSPGSPGPDGKTGPP
CancerPDF_ID CancerPDF_ID7042,
PMID24982608
Protein NameCollagen alpha-1(I) chain
UniprotKB Entry NameCO1A1_HUMAN
FluidUrine
Profiling TechniqueNano-LC-MS
Peptide Identification techniqueMS/MS
Labelled/Label FreeLabel Free
FDR0.01
CancerPDF_ID CancerPDF_ID7042,
p-ValueNA
Software"GPM search engine, MASCOT"
Length14
Cancer TypeOvarian cancer
DatabaseIPI 3.71 Human Database
ModificationNA
Number of Patients6 Ovarian cancer patients and 6 normal individuals
RegulationUniquely present in case of urine of ovarian cancer patients
ValidationNA
SensitivityNA
SpecificityNA
AccuracyNA
Peptide AtlasNA
IEDBNA
Primary information
sequence IDSeq_8021
Peptide sequenceSpGSPGPDGKTGPp
CancerPDF_ID CancerPDF_ID3560,
PMID27026199
Protein NameCollagen alpha-1(I) chain
UniprotKB Entry NameCO1A1_HUMAN
FluidUrine
fdr1281.58
Profiling Technique"CE-MS, Micro-TOF-MS"
Peptide Identification techniqueMS-MS
Labelled/Label FreeLabel Free
CancerPDF_ID CancerPDF_ID3560,
p-Valueless than 0.05
SoftwareProteome Discoverer 1.2
Length14
Cancer TypeBladder cancer
DatabaseUniprot Human non-redundant Database
Modificationp:Hydroxy-Proline
Number of Patients 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls)
RegulationDifferentially expressed between recurrence of UBC vs recurrence control
ValidationIndependent Validation
SensitivityFor testing dataset 88%
SpecificityFor testing dataset 51%
AccuracyNA
Peptide AtlasNA
IEDBNA
Primary information
sequence IDSeq_8022
Peptide sequenceSpGSpGPDGKTGPp
CancerPDF_ID CancerPDF_ID3561,
PMID27026199
Protein NameCollagen alpha1(I) chain
UniprotKB Entry NameCO1A1_HUMAN
FluidUrine
fdr1297.58
Profiling Technique"CE-MS, Micro-TOF-MS"
Peptide Identification techniqueMS-MS
Labelled/Label FreeLabel Free
CancerPDF_ID CancerPDF_ID3561,
p-Valueless than 0.01
SoftwareProteome Discoverer 1.2
Length14
Cancer TypeBladder cancer
DatabaseUniprot Human non-redundant Database
Modificationp:Hydroxy-Proline
Number of Patients 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls)
RegulationDifferentially expressed between recurrence of UBC vs recurrence control
ValidationIndependent Validation
SensitivityFor testing dataset 88%
SpecificityFor testing dataset 51%
AccuracyNA
Peptide AtlasNA
IEDBNA